Business Wire

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic ...

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic ...
Healio

First patient dosed with electron accelerator-produced copper in neuroblastoma study

Please provide your email address to receive an email when new articles are posted on . The first patient has been dosed in a clinical trial with electron accelerator-produced Cu-67, according to a ...
icr.ac.uk

New study explores the use of powerful electron beams to treat cancer

Scientists have explored how a new high-powered laboratory accelerator could one day be used to treat cancer, offering new insights into an emerging form of radiotherapy known as FLASH. Led by a team ...